Evidence map›Paper›PMID 27030122›Full record

ArticlePurinergic signalling2016

Extracellular ATP protects endothelial cells against DNA damage.

Joonas Aho, Mikko Helenius, Sanna Vattulainen-Collanus, Tero-Pekka Alastalo, Juha Koskenvuo

Open access · greenAbstract read
In one paragraph

Article in Purinergic signalling, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 24 citations in OpenAlex.

  1. Purinergic Receptor P2Y2 Activity Prevents DNA Damage in CClJournal of cellular biochemistry · 2025
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Diabetes and hypertension: Pivotal involvement of purinergic signaling.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2021
    Review
  7. Article
  8. Review
  9. Article
  10. The P2-receptor-mediated CaPurinergic signalling · 2019
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Joonas AhoResearch Center of Applied and Preventive Cardiovascular Medicine, University of Turku, Turku, Finland.
Mikko HeleniusChildren's Hospital Helsinki, Pediatric Cardiology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
Sanna Vattulainen-CollanusChildren's Hospital Helsinki, Pediatric Cardiology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
Tero-Pekka AlastaloChildren's Hospital Helsinki, Pediatric Cardiology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland. tero-pekka.alastalo@helsinki.fi.
Juha KoskenvuoResearch Center of Applied and Preventive Cardiovascular Medicine, University of Turku, Turku, Finland.
Helsinki University Hospital · FIUniversity of Turku · FIUniversity of Helsinki · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cell damage can lead to rapid release of ATP to extracellular space resulting in dramatic change in local ATP concentration. Evolutionary, this has been considered as a danger signal leading to adaptive responses in adjacent cells. Our aim was to demonstrate that elevated extracellular ATP or inhibition of ectonucleoside triphosphate diphosphohydrolase 1 (ENTPD1/CD39) activity could be used to increase tolerance against DNA-damaging conditions. Human endothelial cells, with increased extracellular ATP concentration in cell proximity, were more resistant to irradiation or chemically induced DNA damage evaluated with the DNA damage markers γH2AX and phosphorylated p53. In our rat models of DNA damage, inhibiting CD39-driven ATP hydrolysis with POM-1 protected the heart and lung tissues against chemically induced DNA damage. Interestingly, the phenomenon could not be replicated in cancer cells. Our results show that transient increase in extracellular ATP can promote resistance to DNA damage.

Indexed as

Adenosine TriphosphateAnimalsAntigens, CDApyraseBlotting, WesternDNA DamageEndothelial CellsExtracellular SpaceGene Knockdown TechniquesHumansImmunohistochemistryMaleRatsRats, Sprague-DawleyAdenosine TriphosphateAntigens, CDApyraseCD39 antigenATPCancerCD39DNA damageEndothelial cellNTPDase1

Identifiers

PMID27030122
PMCPMC5023623
OpenAlexW2314903700

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.